The deubiquitinase USP28 promotes esophageal squamous cell carcinoma proliferation by stabilizing ΔNp63 protein
Cellular Signalling · 2026-07 · 143 · 112489
DOI: 10.1016/j.cellsig.2026.112489 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cellular Signalling, 2026-07. Verfasst von Changzhou Cai und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou 310016, China. Electronic address: caicz@…. Hauptthemen laut MEDLINE: Esophageal Neoplasms, Ubiquitin Thiolesterase, Esophageal Squamous Cell Carcinoma, Tumor Suppressor Proteins. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China.
Abstract (Originalsprache)
Esophageal squamous cell carcinoma (ESCC) remains a lethal malignancy with limited therapeutic options. The deubiquitinase USP28 has emerged as a key stabilizer of the oncogenic transcription factor ΔNp63 in squamous cancers, yet its functional significance and therapeutic potential in ESCC are unexplored. Here, we elucidate that USP28 is essential for ESCC proliferation. Genetic ablation of USP28 induced profound G2/M cell cycle arrest and apoptosis, phenotypes mechanistically linked to the destabilization of ΔNp63. We further establish that USP28 directly binds to and deubiquitinates ΔNp63, thereby controlling its protein stability. Crucially, targeting this axis with CT1113, a novel and potent USP28 inhibitor, recapitulated the anti-tumor effects of genetic knockdown, triggering ΔNp63 degradation, cell cycle arrest, and apoptosis in ESCC cells. Importantly, CT1113 administration significantly suppressed tumor growth in ESCC xenograft models. Our study not only defines the USP28/ΔNp63 axis as a critical driver of ESCC but also validates the therapeutic strategy of pharmacologically inhibiting USP28 for the treatment of this aggressive cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou 310016, China. Electronic address: caicz@zju.edu.cn.
- Department of Gastroenterology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China.
- Institute of Translational Medicine, Zhejiang University School of Medicine, Hangzhou 310058, China.
- Zhejiang Provincial Key Laboratory of Pancreatic Disease, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China.
- Department of Gastroenterology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou 310016, China. Electronic address: dr_chenxl@zju.edu.cn.
- Department of Gastroenterology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou 310016, China. Electronic address: fyanfei@sina.com.
Förderung
- National Natural Science Foundation of China
- National Key Research and Development Program of China
Zitieren
APA
Cai, C., Cheng, N., Luo, H., Guan, H., Peng, J., Zhang, P., Chen, X., & Fang, Y. (2026). The deubiquitinase USP28 promotes esophageal squamous cell carcinoma proliferation by stabilizing ΔNp63 protein. Cellular Signalling, 143, 112489. https://doi.org/10.1016/j.cellsig.2026.112489
Vancouver
Cai C, Cheng N, Luo H, Guan H, Peng J, Zhang P, et al. The deubiquitinase USP28 promotes esophageal squamous cell carcinoma proliferation by stabilizing ΔNp63 protein. Cellular Signalling. 2026;143:112489. doi:10.1016/j.cellsig.2026.112489
BibTeX
@article{Cai2026,
author = {Cai, Changzhou and Cheng, Nuo and Luo, Hangqi and Guan, Huiyuan and Peng, Jin and Zhang, Pumin and Chen, Xiaoli and Fang, Yanfei},
title = {The deubiquitinase USP28 promotes esophageal squamous cell carcinoma proliferation by stabilizing ΔNp63 protein},
journal = {Cellular Signalling},
year = {2026},
volume = {143},
pages = {112489},
doi = {10.1016/j.cellsig.2026.112489}
}
EUVIMED